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Current techniques for rapid diagnosis of microbial infections by direct detection of the
microbial agent are compared. The techniques include enzyme immunoassay (EIA) tests,
immunofluorescence, latex agglutination assays, and nucleic acid hybridization procedures. It is
concluded that, for the near future, the preferred methods for rapid diagnosis will be by (1) EIA
tests utilizing monoclonal antibodies and improved enzyme detection systems, and (2) improved
latex agglutination procedures for certain antigens. Nucleic acid hybridization techniques, as
currently performed, will need to be substantially improved to become the methods ofchoice.
The need for rapid diagnosis of microbial infections in clinical situations is well
recognized, in that it allows for prompt, appropriate treatment and the institution of
infection control measures in hospital environments. Diagnosis ofinfections by culture
ofthe infectious agent is the standard by which most rapid methods are compared, but
in some cases the agent is either difficult to isolate or has not been cultivated. For these
agents, such as hepatitis viruses, Norwalkvirus, rotavirus, and human papilloma virus,
immunochemical tests are the methods ofchoice. Even for those agents which can be
readily isolated in culture, such as Chlamydia trachomatis and many viruses, the time
required to obtain results is long, the costs are high, and a high degree of expertise is
sometimes required. Thus, rapid and inexpensive methods for detecting these agents
are desirable as well.
The major emphasis in rapid methods has been for enzyme immunoassays (EIA) to
detect antigen. In fact, there have been descriptions of EIA tests for detection of
antigen in clinical specimens for 13 different bacterial species and 13 different viruses
[1]. Only a few of these, however, have been utilized for routine diagnosis, and at
present there are commercially available antigen EIA diagnostic tests for only six
agents: hepatitis B virus, herpes simplex virus, rotavirus, respiratory syncytial virus,
Chlamydia trachomatis, and Neisseriagonorrhoeae. Themajor reason why more EIA
tests are not available is the difficulty in obtaining the sensitivity and specificity that
culture provides. Potential means to improve performance ofthe assays is discussed by
Yolken [2]. These include use of monoclonal antibodies, improved antibody conjuga-
tion methods, increased magnification ofthe antigen-antibody interaction by means of
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sensitive indicator systems, and use ofnucleic acid hybridization techniques. Although
nucleic acid hybridization techniques have not yet been shown to be either rapid or
highly sensitive for detecting microbial agents in clinical specimens, monoclonal
antibodies and amplified indicator systems are becoming effective. Monoclonal
antibodies have been shown to provide both higher sensitivity and higher specificity for
detecting rotavirus than commercially available polyclonal tests [3], and, based on the
limited data available, the use ofan amplified enzyme detector system in combination
with monoclonal antibodies gives both higher sensitivity and higher specificity than
polyclonal antibody tests for detecting C. trachomatis genital infection [4].
Monoclonal antibodies are also being used in latex agglutination assays and have
been found to be sufficiently sensitive for detection ofgroup B streptococcal antigen in
cerebrospinal fluid and concentrated urine specimens [5]. As discussed by Tilton [6],
latex agglutination can also be effectively used for detection of Clostridium difficile
toxins with monoclonal antibodies. Tilton also discusses the chemistry of polystyrene
particles, used in latex suspensions, and discusses newer techniques, such as liposome-
assisted latex agglutination, which offer the possibility of enhanced sensitivity for
latex-based agglutination tests.
One of the major areas in infectious disease targeted for rapid diagnosis is sexually
transmitted disease (STD). The need for rapid diagnosis of STD is to provide for
prompt, appropriate treatment and to eliminate some of the problems encountered in
culture techniques, such as loss ofviability in transport and contamination ofcultures,
especially cell cultures. Also, for diagnosis ofchlamydial infections the costs are high
and the culture procedures are more complex than those for herpes simplex or N.
gonorrhoeae isolation. The use of EIA also permits samples to be tested in automated
or semi-automated formats. One limitation ofthe currently available antigen detection
tests, whether EIA or fluorescent antibody, is that neither is rapid enough to allow for
on-site testing ofspecimens and same-day treatmentofpatients. Anotherdrawback, as
discussed by Schachter [7], is that the specificity of the EIA tests, although
satisfactory for STD clinics, is too low for screening low-risk females. The findings
reported by Schachter [7] for an N. gonorrhoeae EIA (Gonozyme, Abbott Laborato-
ries) in females showed the EIA to be 87 percent sensitive and 98 percent specific,
which is approximately that reported by others. The use offirst-voided urine provides a
simple, non-invasive method for obtaining samples from males for isolation of N.
gonorrhoeae. The use of EIA for testing of these samples has been found to be a
reliable alternative to culture [8], which was confirmed by Schachter [7]. In addition,
the use of EIA has been shown to be superior to culture in situations requiring
transport ofspecimens [9].
Rapid methods for diagnosing C. trachomatis infection by EIA (Chlamydiazyme,
Abbott Laboratories; IDEIA, Boots-Celltech) and by direct fluorescent antibody (FA)
tests (Microtrak, Syva) are also available. The sensitivity ofChlamydiazyme has been
reported to be from 72 percent to 83 percent [10-12] and the specificity from 94
percent to 98 percent [10-12]. The sensitivity and specificity ofthe IDEIA chlamydial
EIA, which utilizes monoclonal antibodies, have been reported to be 95.5 percent and
99 percent, respectively [3]. The polyclonal EIA tests forchlamydial antigens have the
same limitation as the gonococcal EIA tests, that of a low predictive value for positive
tests in low-risk populations [ 1]. It has been found, however, for both the gonococcal
and chlamydial EIA tests that the majority offalse-positive results occur at or near the
cut-off point selected for the assay [12,13]. Thus, if these data are provided by the
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manufacturer of the tests, users should be able to better interpret the reliability of
positive test values obtained in screening low-risk populations.
The sensitivity of the direct FA technique for diagnosing C. trachomatis genital
infection was found by Schachter [7] to be only 70 percent, which is lower than most
reports. Those tested were asymptomatic individuals, which may have been the major
reason for the low sensitivity obtained. Diagnosis ofherpes simplex infection by direct
FA and EIA is also possible with commercially available reagents. The sensitivity of
one EIA (Ortho Diagnostics) has been reported to be only 53 percent and 72 percent
[14,15], which makes this test oflimited value. The results do indicate, however, that
EIA is a feasible approach and with further refinements could be used as an alternative
to culture.
The use of nucleic acid hybridization techniques has also been described for
diagnosis of N. gonorrhoeae [16], herpes simplex [17], and C. trachomatis [18,19].
None, however, has been shown to be higher in sensitivity than EIA for the same
agents, and for C. trachomatis, specificity may also be a problem [19]. The time
required to obtain results is also longer, and most ofthe assays use radioactive probes.
These and other factors in nucleic acid probe technology are discussed in the
accompanying article by Edberg [20]. For probes to become effective for routine
clinical laboratory use, Edberg emphasizes that (I) radioactive markers must be
replaced with non-radioactive ones; (2) the sensitivity needs to be improved, up to
100-fold; (3) the probes must be broadly reactive enough to detect all members of a
given species; and (4) the techniques used need to be simplified and be adaptable to
automation.
In summary, the near future of immunodiagnostic assays should be improved EIA
and latex agglutination tests, followed by application of probe technology. Although
many ofthe current EIA tests for microbial antigens have not realized their potential,
there are reasons to believe this situation will improve. For detection ofantigen, which
offers a rapid and direct means ofdiagnosing microbial infections, the major problem
has been lack of sensitivity. Increasing the sensitivity of polyclonal EIA tests by using
more concentrated immunoreagents or more sensitive enzyme substrates has often
resulted in a loss ofspecificity. From the reports available todate, it appears that useof
the appropriate monoclonal antibodies may solve the problem of sensitivity for
detecting many infectious agents in clinical samples. With the increasing number of
monoclonal antibodies available for various microbial antigens, we can expect that
more of them will be utilized for EIA detection systems. If monoclonal antibodies of
high affinity can be obtained, the EIA tests should be sufficiently sensitive for
detecting most microbial agents in clinical samples.
A similar situation exists with nucleic acid hybridization techniques in regard to
sensitivity. Current tests require the same orhigher number ofinfectious units than are
required for detection by EIA. These tests will also need to be simplified and be able to
provide same-day diagnosis to be practical diagnostic reagents.
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